No Data
No Data
Athira Pharma's Regulatory Compliance Challenges Threaten Drug Development Pipeline
Althira Pharma Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 EPS Results.
Express News | Althira Pharma Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 EPS Results
JMP Securities Maintains Athira(ATHA.US) With Hold Rating
Athira Pharma Reports Q3 2024 Financial Results
JMP Securities Keeps Their Hold Rating on Athira Pharma (ATHA)
No Data
No Data
browny_440 : volume